This cluster is routine post-vesting selling by top executives — the dollar amounts are negligible for a $23B company. The simultaneous option exercises suggest a scheduled vesting event rather than a coordinated bearish signal. No actionable trading signal here; monitor the next 10-Q for any fundamental changes.
Price Chart
Executive Summary
Three top executives at United Therapeutics (CEO, CFO, General Counsel) collectively sold $1.11M in open-market shares over a 5-day window, all following derivative exercises at deep in-the-money strike prices. The sales are consistent with routine post-vesting tax and diversification activity — the total represents ~0.005% of the $23.3B market cap, well below the materiality threshold for informational selling. The cluster is amplified by the cross-filing context (cluster-insider-trades + cluster-earnings-context), but the absolute dollar value is trivial for a company of this size.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 2,926 shares total across 3 days for ~$1.58M, all after exercising options at $146.03
- CFO James Edgemond sold 1,440 shares for ~$785K after exercising options at $117.76
- General Counsel Paul Mahon sold 200 shares for ~$108K after exercising options at $146.03
- Total open-market sales: $1.11M, representing ~0.005% of UTHR's $23.3B market cap
- All three insiders simultaneously exercised options — a pattern consistent with scheduled vesting/expiration, not coordinated bearish conviction
- Historical performance on UTHR reports shows a 17% win rate at T+20 with avg alpha of -6.51%, suggesting the model has over-scored this ticker
Financial Impact
Total insider sales of $1.11M are immaterial relative to $23.3B market cap (0.005%)
Risk Factors
- Insider selling at the C-suite level, even if routine, can weigh on sentiment if the stock is at all-time highs
- The historical calibration shows UTHR reports have underperformed at T+20, suggesting the stock may face headwinds regardless of this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1780608665703 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $573.51 (+14.62%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $573.51 (+15.37%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $573.51 (+13.82%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $573.51 (+13.16%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $573.51 (+17.62%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $573.51 (+17.48%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $573.51 (+11.26%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $573.51 (+8.64%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access